🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Integral Molecular is thrilled to announce an exclusive worldwide antibody license agreement with AstraZeneca to develop therapeutics for multiple cancers. Read More: bit.ly/3mBLQql #IntegralMolecular, #PersonalisedMedicine #AntibodyTherapy

Register now for our webinar with Genetic Engineering & Biotechnology News to learn how SARS-CoV-2 Reporter Virus Particles enable researchers to rapidly test neutralization titers of antibodies and vaccine sera in a safe BSL-2 environment. bit.ly/3n4oKZQ #Biotech

Join our webinar with Genetic Engineering & Biotechnology News on Tuesday, November 30th to learn more about our comprehensive catalog of over 65 SARS-CoV-2 variant RVPs. Stay tuned for a live Q & A after the presentations! #biotech #webinar Register: bit.ly/3cqeBQZ

Join us TOMORROW for our free webinar "Combatting SARS-CoV-2 Variants: Neutralization Testing from Alpha to Mu," sponsored by Integral Molecular. There's still time to register today: ow.ly/yHf250GYaIY #SARSCoV2 #COVID19

We are thrilled to announce a collaboration with Alloy Therapeutics to leverage their ATX-Gx™ humanized mice for antibody discovery, using our MPS antibody discovery platform. Read More: bit.ly/3F06O8l

Join our users' group to learn more about our extensive catalog of SARS-CoV-2 Reporter Virus Particles (RVPs, pseudotyped viruses) including Omicron, and their role in safe neutralization assessment. Register Here: bit.ly/3FNBKcs

There's still time to register for our users' group tomorrow; Tuesday, February 15th, 11am EST. Tune in to learn about our extensive catalog of SARS-CoV-2 Reporter Virus Particles (RVPs, pseudotyped viruses) including Omicron. Register with the link below! bit.ly/3rMiQyI

We are thrilled to announce a partnership with Philadelphia FIGHT! We hope that our donations will help promote healthcare access and equity in Philadelphia. Read more: bit.ly/3CDhzOw

Join Rachel Fong at her poster presentation at the Society of Toxicology Annual 2022 meeting. Fill out the form linked below to schedule a time to get further information on upcoming conferences and our technologies! bit.ly/3COCU7z

Integral Molecular is excited to announce that the FDA has accepted the MPA antibody specificity test into its ISTAND Drug Development Tools pilot program. Read more in Endpoints News: bit.ly/3B4cnmp #drugdevelopment #integralmolecular #philadelphia

Is complex co-culture with primary/immortal cell lines your thing? Are cytokines and flow cytometry your lab language? Join our team to improve human health by combining novel technologies and the human proteome library. Learn more and apply today. bit.ly/3rcDirH

Join us Thursday, November 10 for our free webinar! Dr. Hayley Crawford will discuss Integral Molecular broad catalog of RVPs, including influenza A and B, Marburg virus, and the latest variants of SARS-CoV-2, and more! Register today: ow.ly/3WwA50L93pL

Join our webinar with Genetic Engineering & Biotechnology News on Thursday, November 10th, at 8 am PT, 11 am ET. Stay tuned after for a live Q & A with our panelists: Hayley Crawford, Sheila Keating, and Natalie Anosova. Learn more and register today: bit.ly/3ex9svi

On today's Tech Snapshot® , Integral Molecular shares the applications and advantages of #lipoparticles and how they are a key technology involved in the discovery and characterization of #antibodies for complex membrane proteins. Continue reading: app.scientist.com/blog/2022/10/2…

Our very own Jazmean Williams is featured as the newest Talent Ambassador for the CEO Council for Growth and the Chamber of Commerce. Jazmean describes why she enjoys calling Philly neighborhoods home for both work and play. See video: bit.ly/3ETN8pZ

For over 20 years, our scientists have used their deep expertise in virology to research immune responses and respond to prevalent viral threats. Learn more about how our Reporter Virus Particles (non-replicating pseudotyped viral particles), can enable your research program.

Warm wishes for a peaceful and joyous holiday season, from all of us at Integral Molecular.

Wishing you all the successes for 2023! May your antibodies bind strongly and your assays run true.

Yesterday, we celebrated the grand opening of Integral Molecular’s new headquarters and research site. This new space will enable the company to grow its team to 200 employees and add 100 new technology jobs to the city.

Exciting news from Integral Molecular! We are thrilled to announce the opening of our new research center in Philadelphia’s uCity Square, which includes state-of-the-art pandemic preparedness laboratories. Read more: bit.ly/3Hrhwcf